Effectiveness of Office Hysteroscopy on a Patient’s Health-Related Quality of Life (HRQoL): a Prospective Observational Study

Objective: To determine the effect of office hysteroscopy on a patient’s health-related quality of life (HRQoL) pre-hysteroscopy, 2 weeks, and 6–8 weeks post-hysteroscopy using the EuroQoL-5 Dimension-5 Level (EQ-5D-5L) health status questionnaires and EuroQoL visual analogue scale (EQ-VAS). Study Design: Prospective observational study was done between May 30th, 2023 to June 30th, 2024. One hundred and three (103) patients were included and each completed the questionnaires at three different time points. Paired T-test analyses were used to determine statistical significance. Setting: Private practice office setting Participants: Women, aged 18 and older, meeting the inclusion criteria and scheduled to undergo hysteroscopy in the office setting for diagnosis and treatment purposes, were enrolled. The inclusion criteria include abnormal uterine bleeding, heavy menstrual bleeding, postmenopausal bleeding, abnormal pelvic ultrasound with abnormal endometrial thickening, and/or intrauterine lesions. The exclusion criteria included pregnancy, active pelvic infection, confirmed cervical or endometrial cancer. Women who withdrew voluntarily from the study were also excluded. Interventions: All subjects were asked to complete the EuroQoL-5D-5L questionnaire and then rate their overall health on the EQ-VAS scale before office hysteroscopy, 2-weeks post and 6-8 weeks post-hysteroscopy, respectively. Results: Of the 176 patients scheduled, 103 were included in the final analysis. Significant improvements (p